Why is Tatva Chintan Pharma Chem Ltd ?
1
Company has a Debt to Equity ratio (avg) of 0.08 times
2
With a growth in Net Profit of 54.84%, the company declared Very Positive results in Jan 70
3
Majority shareholders : Promoters
4
Market Beating Performance
- Even though the market (BSE500) has generated negative returns of -2.22% in the last 1 year, the stock has been able to generate 69.70% returns
How much should you buy?
- Overall Portfolio exposure to Tatva Chintan should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Tatva Chintan for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Tatva Chintan
74.4%
1.47
52.73%
Sensex
-8.12%
-0.66
13.59%
Quality key factors
Factor
Value
Sales Growth (5y)
9.35%
EBIT Growth (5y)
-1.26%
EBIT to Interest (avg)
11.11
Debt to EBITDA (avg)
1.17
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.59
Tax Ratio
25.56%
Dividend Payout Ratio
40.95%
Pledged Shares
0
Institutional Holding
7.04%
ROCE (avg)
10.14%
ROE (avg)
8.01%
Valuation Key Factors 
Factor
Value
P/E Ratio
80
Industry P/E
42
Price to Book Value
5.37
EV to EBIT
61.87
EV to EBITDA
39.87
EV to Capital Employed
4.83
EV to Sales
7.75
PEG Ratio
0.13
Dividend Yield
0.11%
ROCE (Latest)
6.30%
ROE (Latest)
5.38%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Bullish
Technical Movement
Footer loading






